147 related articles for article (PubMed ID: 1265343)
1. An evaluation of the hot plate technique to study narcotic antagonists.
Heilman RD; Gray MI; Chen RP; Hahn EF; Fishman J
Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):635-47. PubMed ID: 1265343
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia].
Yan LD; Gong ZH; Yao XJ; Qin BY
Yao Xue Xue Bao; 2003 Aug; 38(8):578-81. PubMed ID: 14628446
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
O'Callaghan JP; Holtzman SG
J Pharmacol Exp Ther; 1975 Mar; 192(3):497-505. PubMed ID: 1168252
[TBL] [Abstract][Full Text] [Related]
4. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
Porter SJ; Somogyi AA; White JM
Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
[TBL] [Abstract][Full Text] [Related]
6. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
Pircio AW; Gylys JA
J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
[TBL] [Abstract][Full Text] [Related]
7. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.
Harris RA
J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766
[TBL] [Abstract][Full Text] [Related]
8. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC
Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176
[No Abstract] [Full Text] [Related]
9. A rapid, quantitative in vivo assay for narcotic antagonists.
Katovich MJ; Simpkins JW; Song IC; Bodor N; Tuttle R
Subst Alcohol Actions Misuse; 1984; 5(2):87-95. PubMed ID: 6540897
[TBL] [Abstract][Full Text] [Related]
10. Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.
Wilhelm JA; Veng-Pedersen P; Zakszewski TB; Osifchin E; Waters SJ
Int J Clin Pharmacol Ther; 1995 Oct; 33(10):540-5. PubMed ID: 8574503
[TBL] [Abstract][Full Text] [Related]
11. Limitations on the antagonistic actions of opioid antagonists.
Young AM; Woods JH
Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.
Shannon HE; Holtzman SG
Psychopharmacology (Berl); 1976 Nov; 50(2):119-24. PubMed ID: 826950
[TBL] [Abstract][Full Text] [Related]
13. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice.
Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ
Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969
[TBL] [Abstract][Full Text] [Related]
14. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
Caruso TP; Larson DL; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
[TBL] [Abstract][Full Text] [Related]
16. Long-acting narcotic antagonist complexes.
Gray AP; Guardina WJ
Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):21-6. PubMed ID: 967231
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.
He GA; Hou HM; Liu XJ
Acta Pharmacol Sin; 2001 Jun; 22(6):530-3. PubMed ID: 11747760
[TBL] [Abstract][Full Text] [Related]
18. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
Valentino RJ; Herling S; Woods JH; Medzihradsky F; Merz H
J Pharmacol Exp Ther; 1981 Jun; 217(3):652-9. PubMed ID: 6262493
[No Abstract] [Full Text] [Related]
19. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
20. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
